Matthew A Whitman

ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 6

Top Venues

bioRxiv : the preprint server for biology

Proceedings of the National Academy of Sciences of the United States of America

Cancer research

Nature biomedical engineering

Cornell University (PHD)

This page only lists publications with an associated author ORCID identifier.

Education History

Cornell University Aug 15 2017

United States

PHD :: Biomedical Engineering

Publications

Matthew A Whitman, Madhav Mantri, Emmanuel Spanos, Lara A Estroff, Iwijn De Vlaminck, Claudia Fischbach
Bone mineral density affects tumor growth by shaping microenvironmental heterogeneity. bioRxiv : the preprint server for biology (2024)
Matthew A Whitman, Madhav Mantri, Emmanuel Spanos, Lara A Estroff, Iwijn De Vlaminck, Claudia Fischbach
Bone mineral density affects tumor growth by shaping microenvironmental heterogeneity. bioRxiv : the preprint server for biology (2024)
Siyoung Choi, Matthew A Whitman, Adrian A Shimpi, Nicole D Sempertegui, Aaron E Chiou, Joseph E Druso, Akanksha Verma, Stephanie C Lux, Zhu Cheng, Matthew Paszek, Olivier Elemento, Lara A Estroff, Claudia Fischbach
Bone-matrix mineralization dampens integrin-mediated mechanosignalling and metastatic progression in breast cancer. Nature biomedical engineering (2023)
Cara M Robertus, Sarah M Snyder, Stephanie M Curley, Shamanth D Murundi, Matthew A Whitman, Claudia Fischbach, David A Putnam
Selective Accumulation of Near Infrared-Labeled Multivalent Quinidine Copolymers in Tumors Overexpressing P-Glycoprotein: Potential for Noninvasive Diagnostic Imaging. ACS applied bio materials (2023)
Jesse C Patterson, Andreas Varkaris, Peter J P Croucher, Maya Ridinger, Susan L Dalrymple, Mannan Nouri, Fang Xie, Shohreh Varmeh, Oliver Jonas, Matthew A Whitman, Sen Chen, Saleh Rashed, Lovemore Makusha, Jun Luo, John T Isaacs, Mark G Erlander, David J Einstein, Steven P Balk, Micheal B Yaffe
Plk1 Inhibitors and Abiraterone Synergistically Disrupt Mitosis and Kill Cancer Cells of Disparate Origin Independently of Androgen Receptor Signaling. Cancer research (2022)
Nimrat Chatterjee, Matthew A Whitman, Cynthia A Harris, Sophia M Min, Oliver Jonas, Evan C Lien, Alba Luengo, Matthew G Vander Heiden, Jiyong Hong, Pei Zhou, Michael T Hemann, Graham C Walker
REV1 inhibitor JH-RE-06 enhances tumor cell response to chemotherapy by triggering senescence hallmarks. Proceedings of the National Academy of Sciences of the United States of America 117 (46) (2020)

Matthew A Whitman.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Matthew A Whitman